Safety

Company wins U.S. contract for anthrax vaccine

Emergency Management Alert, January 28, 2003

Vaccine maker Avant Immunotherapeutics said January 22 it won a U.S. government contract to work on an oral vaccine to protect troops against both anthrax and plague infections, Reuters reports.

The vaccine will use the cholera bacterium as a "bus" to carry in proteins to protect against plague, anthrax, and cholera. However, it could be years before a working vaccine emerges. One of the objections to the current anthrax vaccine is that it causes soreness at the injection site, but an oral vaccine would have no such side effect.

The U.S. Department of Defense contracted the work to DynPort Vaccine Company, which in turn subcontracted to Avant, a Needham, MA-based biotechnology company specializing in vaccines.

    Hospital Safety Center
  • Hospital Safety Center

    Improve compliance with hospital safety standards from The Joint Commission, OSHA, and other regulators with this...

  • Healthcare Life Safety Compliance

    Learn Life Safety Code tips and interpretations for healthcare facilities with this in-depth monthly resource.

  • Hospital Safety Connection

    Stay on top of hospital safety requirements and best practices with our free, fast-paced weekly update.

  • Administering Your OSHA Program

    This course will help an employee new to the role of OSHA safety officer. It gives an overview of OSHA requirements and...

  • Medical OSHA Manual Combo

    Get into compliance with Quality America's OSHA Safety Program Manual and stay in compliance with OSHA Watch Newsletter...

Most Popular

Related Articles